MA26216A1 - Nouveaux composes - Google Patents

Nouveaux composes

Info

Publication number: MA26216A1
Authority: MA; Morocco
Prior art keywords: new compounds; compounds; new
Prior art date: 2001-09-13

Application number

MA27573A

Other languages

English (en)

Inventor

Harshad Kantilal Rami

Mervyn Thompson

Paul Adrian Wyman

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-09-13

Filing date

2004-03-12

Publication date

2004-07-01

2001-09-13 Priority claimed from GB0122156A external-priority patent/GB0122156D0/en

2001-12-20 Priority claimed from GB0130505A external-priority patent/GB0130505D0/en

2001-12-20 Priority claimed from GB0130503A external-priority patent/GB0130503D0/en

2001-12-20 Priority claimed from GB0130547A external-priority patent/GB0130547D0/en

2004-03-12 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

2004-07-01 Publication of MA26216A1 publication Critical patent/MA26216A1/fr

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Pulmonology (AREA)
Dermatology (AREA)
Hospice & Palliative Care (AREA)
Cardiology (AREA)
Urology & Nephrology (AREA)
Diabetes (AREA)
Heart & Thoracic Surgery (AREA)
Hematology (AREA)
Psychiatry (AREA)
Rheumatology (AREA)
Vascular Medicine (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Hydrogenated Pyridines (AREA)

MA27573A 2001-09-13 2004-03-12 Nouveaux composes MA26216A1 (fr)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GB0122156A GB0122156D0 (en)	2001-09-13	2001-09-13	Novel compounds
GB0130505A GB0130505D0 (en)	2001-12-20	2001-12-20	Novel compounds
GB0130503A GB0130503D0 (en)	2001-12-20	2001-12-20	Novel compounds
GB0130547A GB0130547D0 (en)	2001-12-20	2001-12-20	Novel compounds

Publications (1)

Publication Number	Publication Date
MA26216A1 true MA26216A1 (fr)	2004-07-01

Family

ID=27447989

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA27573A MA26216A1 (fr)	2001-09-13	2004-03-12	Nouveaux composes

Country Status (31)

Country	Link
US (1)	US8063078B2 (fr)
EP (3)	EP2036902A3 (fr)
JP (2)	JP4463552B2 (fr)
KR (3)	KR20100082390A (fr)
CN (1)	CN1247568C (fr)
AP (1)	AP1818A (fr)
AR (1)	AR038786A1 (fr)
AT (1)	ATE420083T1 (fr)
AU (1)	AU2002329397B2 (fr)
BR (1)	BR0212468A (fr)
CA (1)	CA2458632C (fr)
CY (1)	CY1109449T1 (fr)
DE (1)	DE60230773D1 (fr)
DK (1)	DK1425277T3 (fr)
EA (1)	EA007731B1 (fr)
ES (1)	ES2316607T3 (fr)
HU (1)	HUP0401923A3 (fr)
IL (2)	IL160755A0 (fr)
MA (1)	MA26216A1 (fr)
MX (1)	MXPA04002379A (fr)
MY (1)	MY138086A (fr)
NO (3)	NO327009B1 (fr)
NZ (1)	NZ531137A (fr)
OA (1)	OA12659A (fr)
PE (1)	PE20030417A1 (fr)
PL (1)	PL213639B1 (fr)
PT (1)	PT1425277E (fr)
SI (1)	SI1425277T1 (fr)
TW (1)	TWI283665B (fr)
UY (1)	UY27446A1 (fr)
WO (1)	WO2003022809A2 (fr)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MY138086A (en) *	2001-09-13	2009-04-30	Smithkline Beecham Plc	Novel urea derivative as vanilloid receptor-1 antagonist
DK1472225T3 (da)	2002-02-01	2010-08-09	Euro Celtique Sa	2-Piperazinpyridiner, som er anvendelige til behandling af smerte
US7074805B2 (en)	2002-02-20	2006-07-11	Abbott Laboratories	Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
MXPA04008073A (es) *	2002-02-20	2004-11-26	Abbott Lab	Compuestos azabiciclicos fusionados que inhiben el receptor de subtipo 1 (vr1) del receptor de vainilloide.
US6974818B2 (en)	2002-03-01	2005-12-13	Euro-Celtique S.A.	1,2,5-thiadiazol-3-YL-piperazine therapeutic agents useful for treating pain
DK1556354T3 (da)	2002-06-28	2008-06-02	Euro Celtique Sa	Terapeutiske piperazinderivater, der er egnede til behandling af smerter
US7262194B2 (en)	2002-07-26	2007-08-28	Euro-Celtique S.A.	Therapeutic agents useful for treating pain
GB0221157D0 (en) *	2002-09-12	2002-10-23	Glaxo Group Ltd	Novel treatment
WO2004024710A1 (fr) *	2002-09-13	2004-03-25	Glaxo Group Limited	Composes a base d'uree, actifs en tant qu'antagonistes du recepteur de la vanilloide et utilises pour traiter les douleurs
US7157462B2 (en)	2002-09-24	2007-01-02	Euro-Celtique S.A.	Therapeutic agents useful for treating pain
AU2003294748A1 (en)	2002-12-06	2004-06-30	Bayer Healthcare Ag	Tetrahydro-naphthalene derivatives
GB0229808D0 (en) *	2002-12-20	2003-01-29	Glaxo Group Ltd	Novel compositions
US6933311B2 (en) *	2003-02-11	2005-08-23	Abbott Laboratories	Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
ATE440835T1 (de) *	2003-03-06	2009-09-15	Glaxo Group Ltd	Heterozyklische harnstoff-derivate für die behandlung von schmerzen.
WO2004078744A2 (fr) *	2003-03-07	2004-09-16	Glaxo Group Limited	Derives d'uree
GB0305426D0 (en)	2003-03-08	2003-04-16	Glaxo Group Ltd	Novel compounds
SE0301446D0 (sv)	2003-05-16	2003-05-16	Astrazeneca Ab	New Compounds
WO2004103954A1 (fr)	2003-05-20	2004-12-02	Ajinomoto Co., Inc.	Derive d'amide
EP1493438A1 (fr) *	2003-07-03	2005-01-05	Bayer HealthCare AG	Inhibiteurs du recepteur vanilloide (VR1) dans le traitement de la douleur associée au VIH
GB0319150D0 (en)	2003-08-14	2003-09-17	Glaxo Group Ltd	Novel compounds
GB0319151D0 (en) *	2003-08-14	2003-09-17	Glaxo Group Ltd	Novel compounds
DE602004032276D1 (de)	2003-10-01	2011-05-26	Xention Ltd	Tetrahydro-Naphthalen und Harnstoffderivate
JP4935073B2 (ja)	2003-10-14	2012-05-23	味の素株式会社	エーテル誘導体
JP2007509846A (ja) *	2003-10-15	2007-04-19	バイエル・ヘルスケア・アクチェンゲゼルシャフト	テトラヒドロ−ナフタレンおよび尿素誘導体
WO2005044802A2 (fr)	2003-11-08	2005-05-19	Bayer Healthcare Ag	Derives de tetrahydro-quinolinyluree
EP1736465A4 (fr)	2004-03-31	2009-06-17	Ajinomoto Kk	Dérivés d'aniline
JP2008504280A (ja)	2004-06-24	2008-02-14	インサイト・コーポレイション	２−メチルプロパンアミドおよびその医薬としての使用
US7879866B2 (en)	2004-07-19	2011-02-01	Dorte Xenia Gram	Inhibition of the activity of the capsaicin receptor in the treatment of obesity or obesity-related diseases and disorders
KR20060087386A (ko)	2005-01-28	2006-08-02	주식회사 대웅제약	신규 벤조이미다졸 유도체 및 이를 함유하는 약제학적조성물
WO2006098554A1 (fr) *	2005-03-16	2006-09-21	Amorepacific Corporation	Nouveaux composes, isomere de ceux-ci ou sels pharmaceutiquement acceptables de ceux-ci en tant qu’antagonistes du recepteur vanilloide ; et composition pharmaceutique contenant ceux-ci
WO2007046867A2 (fr) *	2005-05-19	2007-04-26	Xenon Pharmaceuticals Inc.	Derives de piperidine et leurs utilisations comme agents therapeutiques
UY30048A1 (es)	2005-12-23	2007-07-31	Astrazeneca Ab	Derivados sustituidos de la n,2-(1h-benzimidazol-1-il) acetamida, composiciones farmacéuticas conteniéndolos, procesos de preparación y aplicaciones
EP1889830A1 (fr) *	2006-07-10	2008-02-20	Pharmeste S.r.l.	Amides biarylcarboxyaryles en tant que modulateurs du recepteur vanilloid-1.
EP1882687A1 (fr) *	2006-07-27	2008-01-30	Amorepacific Corporation	Composés hétérocycliques, leur utilisation comme antagonistes du récepteur vanilloide et les compositions pharmaceutiques qui les contiennent
PL2054411T3 (pl) *	2006-07-27	2015-02-27	Amorepacific Corp	Nowe związki, ich izomery lub ich farmaceutycznie dopuszczalne sole jako antagoniści receptora waniloidowego oraz zawierające je kompozycje farmaceutyczne
TWI433839B (zh)	2006-08-11	2014-04-11	Neomed Inst	新穎的苯并咪唑衍生物290
CA2661898A1 (fr)	2006-08-25	2008-02-28	Abbott Laboratories	Derives d'indazole inhibant trpv1, et leur utilisation
CN101563318A (zh)	2006-12-20	2009-10-21	艾博特公司	作为trpv1香草素受体拮抗剂用于治疗疼痛的n-(5,6,7,8-四氢萘-1-基)脲衍生物以及相关化合物
MX2010010262A (es)	2008-03-20	2010-12-06	Abbott Lab	Metodos para la elaboracion de agentes para el sistema nervioso central que son antagonistas del trpv1.
US8362012B2 (en)	2008-04-18	2013-01-29	Daewoong Pharmaceutical Co., Ltd.	Benzoxazine benzimidazole derivative, a pharmaceutical composition comprising the same, and a use thereof
JP4746713B2 (ja) *	2008-05-07	2011-08-10	大日本住友製薬株式会社	環状アミン−１−カルボン酸エステル誘導体およびそれを含有する医薬組成物
US20110200646A1 (en) *	2008-09-02	2011-08-18	Charanjit Bountra	The TRPVL Antagonists SB-795498 For Treating Rhinitis
WO2010026128A1 (fr) *	2008-09-02	2010-03-11	Glaxo Group Limited	N-(3-méthyl-5-isoquinolinyl)-n'-((3r)-l-[5-(trifluorométhyl)-2-pyridinyl]-3-pyrrolidinyl) urée pour le traitement de la rhinite
JP2013028536A (ja) *	2009-11-11	2013-02-07	Dainippon Sumitomo Pharma Co Ltd	環状アミン−１−カルボン酸エステル誘導体およびそれを含有する医薬組成物
WO2012045729A1 (fr)	2010-10-05	2012-04-12	Glaxo Group Limited	Dérivés d'imidazo[1,2-a]pyridine et de pyrazolo[1,5-a]pyridine en tant qu'antagonistes du trpv1
KR101293384B1 (ko)	2010-10-13	2013-08-05	주식회사 대웅제약	신규 피리딜 벤조옥사진 유도체, 이를 포함하는 약학 조성물 및 이의 용도
WO2012072512A1 (fr)	2010-11-29	2012-06-07	Glaxo Group Limited	Carboxamides de n-cyclo-butylimidazopyridine ou de n-cyclo-pyrazolopyridine comme antagonistes de trpv1
GB201101517D0 (en) *	2011-01-28	2011-03-16	Proximagen Ltd	Receptor antagonists
EP2697221A1 (fr)	2011-04-11	2014-02-19	Glaxo Group Limited	N-cyclobutyl-imidazopyridine-méthylamine à titre d'antagoniste des trpv1
DE102022104759A1 (de)	2022-02-28	2023-08-31	SCi Kontor GmbH	Co-Kristall-Screening Verfahren, insbesondere zur Herstellung von Co-Kristallen

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3424760A (en) *	1966-03-07	1969-01-28	Robins Co Inc A H	3-ureidopyrrolidines
US3424761A (en) *	1966-03-07	1969-01-28	Robins Co Inc A H	3-ureidopyrrolidines
GB1460389A (en) *	1974-07-25	1977-01-06	Pfizer Ltd	4-substituted quinazoline cardiac stimulants
EP0347000B1 (fr)	1988-06-17	1994-10-26	The Procter & Gamble Company	Utilisation de dérivés de la vanilline pour la fabrication d'un médicament utile dans le traitement de l'infection de l'herpes simplex
HU206082B (en)	1988-12-23	1992-08-28	Sandoz Ag	Process for producing capsaicin derivatives and pharmaceutical compositions comprising such compounds
CA2017383A1 (fr)	1989-06-08	1990-12-08	Raymond R. Martodam	Utilisation de vanilloides pour le traitement des affections ou des troubles respiratoires
AU9079491A (en)	1990-11-27	1992-06-25	Procter & Gamble Company, The	Combinations of vanilloid compounds and phosphonate antiviral compounds for treatment of herpes infections
US5149704A (en)	1991-05-03	1992-09-22	Abbott Laboratories	Platelet activating antagonists
CA2197364A1 (fr) *	1996-02-15	1997-08-16	Toshikazu Suzuki	Compose phenolique et methode de preparation
CA2294042A1 (fr)	1997-06-26	1999-01-07	David Kent Herron	Agents antithrombotiques
ES2241151T3 (es)	1997-06-26	2005-10-16	Eli Lilly And Company	Agentes antitromboticos.
JP2000080085A (ja) *	1997-09-01	2000-03-21	Kyorin Pharmaceut Co Ltd	６，７−非対称ジ置換キノキサリンカルボン酸誘導体とその付加塩及びそれらの製造方法
WO2000050387A1 (fr)	1999-02-22	2000-08-31	Pacific Corporation	Analogues de vanilloide contenant des pharmacophores de resiniferatoxine, utilises en tant qu'agonistes du recepteur de vanilloide et analgesiques puissants, compositions et leurs utilisations
ID30176A (id)	1999-03-12	2001-11-08	Boehringer Ingelheim Pharma	Senyawa-senyawa yang bermanfaat sebagai zat anti-inflamasi
EP1220836A2 (fr)	1999-10-15	2002-07-10	Bristol-Myers Squibb Pharma Company	Amines benzyle cycloalkyle comme modulateurs de l'activite du recepteur de la chimiokine
KR20030024799A (ko)	2000-07-20	2003-03-26	뉴로젠 코포레이션	캡사이신 수용체 리간드
EP1303483B1 (fr)	2000-08-21	2008-04-23	Pacific Corporation	Nouveaux derives de thiourea et compositions pharmaceutiques renfermant ceux-ci
EP1311478B1 (fr)	2000-08-21	2006-06-07	Pacific Corporation	Nouveaux composes de (thio)uree et les compositions pharmaceutiques les contenant
WO2002016317A1 (fr)	2000-08-21	2002-02-28	Pacific Corporation	Nouveaux derives d'acide thiocarbamique et compositions pharmaceutiques contenant lesdits derives
JP2002080073A (ja)	2000-09-07	2002-03-19	Kyokuto Kobunshi Kk	電子レンジ用自動開孔袋
JP2002088073A (ja) *	2000-09-08	2002-03-27	Yamanouchi Pharmaceut Co Ltd	抗アンドロゲン剤
GB0110901D0 (en) *	2001-05-02	2001-06-27	Smithkline Beecham Plc	Novel Compounds
MY138086A (en)	2001-09-13	2009-04-30	Smithkline Beecham Plc	Novel urea derivative as vanilloid receptor-1 antagonist
JP2005537247A (ja) *	2002-06-27	2005-12-08	シエーリングアクチエンゲゼルシャフト	置換されたキノリンｃｃｒ５受容体アンタゴニスト
WO2004024710A1 (fr) *	2002-09-13	2004-03-25	Glaxo Group Limited	Composes a base d'uree, actifs en tant qu'antagonistes du recepteur de la vanilloide et utilises pour traiter les douleurs
GB0229808D0 (en)	2002-12-20	2003-01-29	Glaxo Group Ltd	Novel compositions
WO2005103018A1 (fr)	2004-04-20	2005-11-03	Bayer Healthcare Ag	Derives d'uree utilises en tant qu'antagonistes du recepteur vanilloide (vr1)

2002
- 2002-09-11 MY MYPI20023391A patent/MY138086A/en unknown
- 2002-09-11 PE PE2002000895A patent/PE20030417A1/es not_active Application Discontinuation
- 2002-09-11 TW TW091120671A patent/TWI283665B/zh not_active IP Right Cessation
- 2002-09-12 UY UY27446A patent/UY27446A1/es not_active Application Discontinuation
- 2002-09-12 AR ARP020103454A patent/AR038786A1/es active IP Right Grant
- 2002-09-13 AU AU2002329397A patent/AU2002329397B2/en not_active Ceased
- 2002-09-13 PL PL369026A patent/PL213639B1/pl not_active IP Right Cessation
- 2002-09-13 CN CNB028177177A patent/CN1247568C/zh not_active Expired - Fee Related
- 2002-09-13 BR BR0212468-8A patent/BR0212468A/pt not_active IP Right Cessation
- 2002-09-13 DK DK02765023T patent/DK1425277T3/da active
- 2002-09-13 IL IL16075502A patent/IL160755A0/xx unknown
- 2002-09-13 HU HU0401923A patent/HUP0401923A3/hu unknown
- 2002-09-13 DE DE60230773T patent/DE60230773D1/de not_active Expired - Lifetime
- 2002-09-13 PT PT02765023T patent/PT1425277E/pt unknown
- 2002-09-13 EP EP08172882A patent/EP2036902A3/fr not_active Withdrawn
- 2002-09-13 SI SI200230792T patent/SI1425277T1/sl unknown
- 2002-09-13 EP EP02765023A patent/EP1425277B8/fr not_active Expired - Lifetime
- 2002-09-13 EA EA200400432A patent/EA007731B1/ru not_active IP Right Cessation
- 2002-09-13 OA OA1200400070A patent/OA12659A/en unknown
- 2002-09-13 ES ES02765023T patent/ES2316607T3/es not_active Expired - Lifetime
- 2002-09-13 EP EP10179466A patent/EP2298757A3/fr not_active Withdrawn
- 2002-09-13 KR KR1020107014626A patent/KR20100082390A/ko not_active Ceased
- 2002-09-13 KR KR1020047003680A patent/KR101063679B1/ko not_active Expired - Fee Related
- 2002-09-13 CA CA2458632A patent/CA2458632C/fr not_active Expired - Fee Related
- 2002-09-13 WO PCT/GB2002/004206 patent/WO2003022809A2/fr not_active Ceased
- 2002-09-13 AT AT02765023T patent/ATE420083T1/de active
- 2002-09-13 NZ NZ531137A patent/NZ531137A/en not_active IP Right Cessation
- 2002-09-13 US US10/489,277 patent/US8063078B2/en not_active Expired - Fee Related
- 2002-09-13 MX MXPA04002379A patent/MXPA04002379A/es active IP Right Grant
- 2002-09-13 AP APAP/P/2004/002982A patent/AP1818A/en active
- 2002-09-13 KR KR1020097003812A patent/KR100955967B1/ko not_active Expired - Fee Related
- 2002-09-13 JP JP2003526885A patent/JP4463552B2/ja not_active Expired - Fee Related
2004
- 2004-03-04 IL IL160755A patent/IL160755A/en not_active IP Right Cessation
- 2004-03-10 NO NO20041003A patent/NO327009B1/no not_active IP Right Cessation
- 2004-03-12 MA MA27573A patent/MA26216A1/fr unknown
2008
- 2008-12-04 NO NO20085077A patent/NO20085077L/no not_active Application Discontinuation
- 2008-12-04 NO NO20085078A patent/NO20085078L/no unknown
2009
- 2009-03-19 CY CY20091100306T patent/CY1109449T1/el unknown
- 2009-12-08 JP JP2009278584A patent/JP2010100632A/ja active Pending

Also Published As

Publication number	Publication date
PL213639B1 (pl)	2013-04-30
KR101063679B1 (ko)	2011-09-07
EP2036902A2 (fr)	2009-03-18
KR20100082390A (ko)	2010-07-16
US20090163506A1 (en)	2009-06-25
WO2003022809A2 (fr)	2003-03-20
NO20041003L (no)	2004-06-04
ATE420083T1 (de)	2009-01-15
CN1553905A (zh)	2004-12-08
UY27446A1 (es)	2003-04-30
KR20090026369A (ko)	2009-03-12
JP4463552B2 (ja)	2010-05-19
CA2458632C (fr)	2011-08-23
IL160755A0 (en)	2004-08-31
PT1425277E (pt)	2009-03-05
EA200400432A1 (ru)	2004-12-30
EP2298757A2 (fr)	2011-03-23
KR20040041610A (ko)	2004-05-17
PL369026A1 (en)	2005-04-18
NO20085077L (no)	2004-06-04
PE20030417A1 (es)	2003-08-06
DE60230773D1 (de)	2009-02-26
HK1066534A1 (en)	2005-03-24
CY1109449T1 (el)	2014-08-13
KR100955967B1 (ko)	2010-05-04
IL160755A (en)	2009-09-01
NZ531137A (en)	2006-08-31
WO2003022809A3 (fr)	2003-07-17
EP2298757A3 (fr)	2011-12-28
DK1425277T3 (da)	2009-03-16
AP2004002982A0 (en)	2004-03-31
NO20085078L (no)	2004-06-04
CN1247568C (zh)	2006-03-29
HUP0401923A2 (hu)	2005-01-28
EP2036902A3 (fr)	2009-05-06
AP1818A (en)	2008-01-07
AR038786A1 (es)	2005-01-26
HUP0401923A3 (en)	2012-09-28
MY138086A (en)	2009-04-30
EA007731B1 (ru)	2006-12-29
NO327009B1 (no)	2009-04-06
OA12659A (en)	2006-06-19
ES2316607T3 (es)	2009-04-16
BR0212468A (pt)	2004-10-19
AU2002329397B2 (en)	2006-04-27
SI1425277T1 (sl)	2009-04-30
EP1425277B8 (fr)	2009-04-01
US8063078B2 (en)	2011-11-22
CA2458632A1 (fr)	2003-03-20
EP1425277A2 (fr)	2004-06-09
JP2005504074A (ja)	2005-02-10
EP1425277B1 (fr)	2009-01-07
MXPA04002379A (es)	2004-05-31
JP2010100632A (ja)	2010-05-06
TWI283665B (en)	2007-07-11

Publication	Publication Date	Title
MA26216A1 (fr)	2004-07-01	Nouveaux composes
MA27105A1 (fr)	2004-12-20	Nouveaux composes
NO20034026D0 (no)	2003-09-11	Nytt preparat
DK1671949T3 (da)	2008-11-03	Substituerede pyridinylaminer
DE60230376D1 (de)	2009-01-29	Zweirad
DK1421841T3 (da)	2007-12-17	Mejetærsker
ATE524462T1 (de)	2011-09-15	C5-modifizierte indazolylpyrrolotriazine
DE50103741D1 (de)	2004-10-28	Welle-Nabe-Verbindung
DE10292917D2 (de)	2004-07-22	Fahrrad
DE50206892D1 (de)	2006-06-29	Substituierte imidazotriazinone
ATE335486T1 (de)	2006-09-15	Hydrazono-malonitrile
NO20034695L (no)	2003-12-03	Nytt preparat
DK1373228T3 (da)	2008-08-04	Substituerede fluoralkoxyphenylsulfonylurinstoffer
ITMI20020275V0 (it)	2002-05-27	Bicicletta
ATE355059T1 (de)	2006-03-15	Isoxazolopyridinone
ATE435197T1 (de)	2009-07-15	Substituierte 4-aminocyclohexanole
FI20010129A0 (fi)	2001-01-22	Kaksiviiraformeri
MA25651A1 (fr)	2002-12-31	Composes caldilytiques
ATA18372001A (de)	2005-07-15	Gelenksbolzenbaueinheit
ATE319694T1 (de)	2006-03-15	Phenylalkyne
ATA13992002A (de)	2003-10-15	Schlackengranulierungsanlage
DE60110464D1 (de)	2005-06-02	Federball
DE10295006D2 (de)	2004-10-07	Bauwerksabdichtung
DE50108381D1 (de)	2006-01-19	Synchronisierschaltungsanordnung
EP1635834A4 (fr)	2009-12-02	Nouveaux composes